Back to search
MMR on 12 Month
Clinical trial pipeline · Data from ClinicalTrials.gov
See which MMR on 12 Month trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which MMR on 12 Month trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
patients with Ph+ CML-CP who have been treated with second-generation TKIs (nilotinib, dasatinib) for at least 3 years and maintains MMR for at least 2 years, c…
Compare MMR on 12 month treated with half TKIs(including imatinib, dasatinib, and nilotinib) or TKIs withdrawal.